Sign In
Buy ACAD
$22.60
+0.510 (+2.31%)
At Close: Jun 23, 2026
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) President Srdjan R. Stankovic Sells 54,019 Shares
08:12am, Thursday, 23'rd Apr 2020
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) President Srdjan R. Stankovic sold 54,019 shares of the stock in a transaction dated Wednesday, April 22nd. The stock was sold at an average price of $50.02,
Srdjan R. Stankovic Sells 100,000 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Stock
08:12am, Thursday, 23'rd Apr 2020
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) President Srdjan R. Stankovic sold 100,000 shares of the business’s stock in a transaction dated Monday, April 20th. The shares were sold at an average pric
Biogen (BIIB) Receives a Buy from Oppenheimer
12:25am, Thursday, 23'rd Apr 2020
The company's shares closed last Wednesday at $298.01. According to TipRanks.com, Olson 's ranking currently consits of no stars on a 0-5 ranking scale,
Biogen (BIIB) Receives a Buy from Oppenheimer
12:25am, Thursday, 23'rd Apr 2020
The company’s shares closed last Wednesday at $298.01. According to TipRanks.com, Olson ‘s ranking currently consits of no stars on
Analysts Offer Insights on Healthcare Companies: Biohaven Pharmaceutical Holding Co (BHVN) and Cara Therapeutics (CARA)
10:17am, Wednesday, 22'nd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biohaven Pharmaceutical Holding Co (BHVN) and Cara
Analysts Offer Insights on Healthcare Companies: Biohaven Pharmaceutical Holding Co (NYSE: BHVN) and Cara Therapeutics (NASDAQ: CARA)
10:17am, Wednesday, 22'nd Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biohaven Pharmaceutical Holding Co (
BHVN
–
Research Report
) and Cara Therapeutics (
CARA
–
Resear
Cara Therapeutics (CARA) Receives a Buy from Needham
03:58pm, Tuesday, 21'st Apr 2020
In a report released today, Alan Carr from Needham assigned a Buy rating to Cara Therapeutics (CARA), with a price target of $35.00. The company's shares
Cara Therapeutics (CARA) Receives a Buy from Needham
03:58pm, Tuesday, 21'st Apr 2020
In a report released today, Alan Carr from Needham assigned a Buy rating to Cara Therapeutics (CARA – Research Report),
Needham Gives a Buy Rating to SCYNEXIS (SCYX)
03:52pm, Tuesday, 21'st Apr 2020
Needham analyst Alan Carr assigned a Buy rating to SCYNEXIS (SCYX) today and set a price target of $5.00. The company's shares closed last Tuesday at
Needham Gives a Buy Rating to SCYNEXIS (SCYX)
03:52pm, Tuesday, 21'st Apr 2020
Needham analyst Alan Carr assigned a Buy rating to SCYNEXIS (SCYX – Research Report) today and set a price target
2,000 Shares in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Purchased by Allred Capital Management LLC
08:09am, Monday, 20'th Apr 2020
Allred Capital Management LLC bought a new position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) during the 1st quarter, HoldingsChannel reports. The institutional investor bought 2,000 shar
Q1 2020 Earnings Forecast for ACADIA Pharmaceuticals Inc. Issued By Jefferies Financial Group (NASDAQ:ACAD)
06:00am, Monday, 20'th Apr 2020
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) – Research analysts at Jefferies Financial Group issued their Q1 2020 earnings per share (EPS) estimates for shares of ACADIA Pharmaceuticals in a report is
The Stock Market Has Gone Insane
08:44pm, Saturday, 18'th Apr 2020
The Fed has made everything right in the world. Earnings don’t matter; valuations do not matter. Why even bother trying to invest any more. Just take all your money and stick it in the SPY and forge
Analysts Conflicted on These Healthcare Names: Alexion Pharmaceuticals (ALXN) and Varian Medical Systems (VAR)
07:41pm, Friday, 17'th Apr 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alexion Pharmaceuticals (ALXN) and Varian Medical Systems
